<?xml version="1.0" encoding="UTF-8"?>
<svg height="762.505" width="542.9346971250001" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <text x="516.338,520.786,525.234" y="752.496" svg_rhmargin="529.682" style="fill:#171615;font-family:RPCELK+Frutiger-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">989</text>
  <text x="57.146,62.347,64.154,67.768,71.382,74.995,78.609,80.416,83.666,87.28,90.53,92.337,96.673,100.287,102.451,106.065,109.679,111.844,114.372,116.179" y="752.505" svg_rhmargin="117.986" style="fill:#171615;font-family:KHQORY+Frutiger-Light;font-size:6.5px;font-style:NORMAL;font-weight:normal;">© 2018 The Authors. </text>
  <text x="117.986,121.958,125.208,128.822,131.708,134.958,137.122,138.93,144.708,147.958,151.572,153.015,155.901,157.344,160.958" y="752.505" svg_rhmargin="164.208" style="fill:#171615;font-family:IERCPC+Frutiger-LightItalic;font-size:6.5px;font-style:ITALIC;font-weight:normal;">Cancer Medicine</text>
  <text svg_rhmargin="268.033" y="65.11699999999996" x="166.015,169.629,173.243,176.857,178.3,179.743,182.271,185.885,189.135,192.749,194.556,198.17,201.056,202.863,205.028,208.642,212.256,215.87,217.677,223.969,225.412,226.855,230.105,232.991,234.798,239.133,240.941,244.191,247.805,251.419,253.947,255.754,258.64,260.805,264.419,266.226,268.033" style="fill:#171615;font-family:KHQORY+Frutiger-Light;font-size:6.5px;font-style:NORMAL;font-weight:normal;">published by John Wiley &amp; Sons Ltd. </text>
  <text x="378.25,385.33,389.5,392.418,396.588,399.086,399.085,403.255,407.838,412.008,414.093,417.843,420.76,422.845,425.763,427.848,432.43,435.348,437.433,444.933,449.515,453.964,458.134,460.219,464.389,466.474,471.056,473.974,476.059,480.229,487.309,491.479,493.564,497.734,502.316,506.899,508.984,516.484,521.066,525.514" y="65.11699999999996" svg_rhmargin="529.684" style="fill:#171615;font-family:LGAUFW+Frutiger-Roman;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Meta- analysis of WBRT Plus TMZ and WBRT</text>
  <text x="57.145,60.985,63.07,65.155,69.738,71.403,75.573,77.658,81.408,83.905,85.99,89.74,91.405" y="65.11699999999996" svg_rhmargin="93.49" style="fill:#171615;font-family:KHQORY+Frutiger-Light;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Y. Xin et al.</text>
  <text x="57.146,63.588,66.115,69.05,74.114,76.299,79.795,84.811,88.297,93.427,97.759,101.132,103.411,105.596,109.092,114.137,118.279,121.766,126.098,130.088,132.368,134.553,138.049,143.112,145.639,149.971,155.035,158.502,158.492,163.356,168.486,172.628,175.022,177.549,180.485,184.731,187.011,189.196,192.692,197.708,202.62,207.75,212.643,215.036,219.027,222.494,222.494,227.386,229.78,232.307,237.494,242.51,244.695,248.191,251.127,254.613,257.14,261.282,263.676,267.049,269.234,272.73,276.872,280.358,284.348" y="95.91200000000003" svg_rhmargin="286.533" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">with drugs. Large, high- quality, double- blind trials are </text>
  <text x="57.146,62.333,66.323,70.313,75.329,79.319,84.335,86.52,89.836,92.771,97.683,99.86800000000001,103.183,107.145,112.056,117.243,122.44,125.926,133.754,135.939,139.255,142.19,147.254,151.244,153.429,156.745,160.735,163.537,168.734,172.695,175.222,179.212,184.399,188.361,192.607,194.792,198.108,203.019,205.822,208.007,211.322,220.29,225.857,231.766,237.523,239.708,243.024,248.04,250.434,255.564,258.936,261.121,264.437,270.194,278.677,284.368" y="107.91099999999994" svg_rhmargin="286.553" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">needed to confirm the efficiency of WBRT plus TMZ </text>
  <text x="57.146,60.661,65.221,69.781,73.296,75.576,77.761,80.554,86.311,91.375,95.365,97.55,100.343,105.254,110.27,113.206,115.733,123.561,127.703,130.097,132.282,135.075,142.903,147.814,152.83,156.82,159.005,161.798,165.94,171.127,176.143,178.328,181.121,186.137,191.049,194.421,198.411,200.596,203.389,208.301,211.103,213.288,216.081,219.568,223.71,228.726,231.253,236.164,239.1,244.163,248.153,251.64,255.782,260.798,265.044,267.229,270.022,274.164,279.351,284.367" y="119.90899999999999" svg_rhmargin="286.552" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">[26]. The optimal mode and dose of radiotherapy and </text>
  <text x="57.146,61.108,66.171,70.161,77.989,82.901,85.836,90.9,94.89,98.376,102.518,107.534,111.781,113.96600000000001,116.151,120.293,122.687,126.059,130.971,133.156,135.341,140.528,144.518,148.508,153.524,156.896,159.081,161.266,164.069,169.199,172.685,175.621,180.684,184.674,188.161,190.346,192.531,196.017,200.007,203.38,207.37,211.512,214.998,218.96,224.023" y="131.90800000000002" svg_rhmargin="226.303" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">chemotherapy also needs further research.</text>
  <text x="57.146,66.093,71.843,78.87,86.54,94.222,105.078,108.92,115.946,123.628,131.31,142.81,149.837,157.507,162.613" y="161.91200000000003" svg_rhmargin="168.363" style="fill:#171615;font-family:PMDSJO+Frutiger-Black;font-size:11.5px;font-style:NORMAL;font-weight:bold;">Acknowledgments</text>
  <text x="57.146,66.115,70.104,72.289,72.926,75.862,80.925,85.067,90.254,94.909,97.09400000000001,97.73,100.666,105.729,109.719,111.904,112.541,117.728,121.87,124.805,127.332,131.674,135.664,137.849,138.486,143.749,148.936,153.268,155.661,158.188,161.561,166.624,170.092,170.092,173.464,178.48,182.471,186.613,191.268,193.794,198.981,203.313,205.498,206.135,209.507,213.469,215.996,219.986,225.173,228.108,230.635,234.008,236.943,240.316,242.501,243.137,248.049,250.851,253.036,253.673,258.936,261.33,263.857,268.313,270.84,275.172,279.161,284.349" y="179.91200000000003" svg_rhmargin="286.534" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">We thank the native English- speaking scientists of Elixigen </text>
  <text x="57.146,63.407,68.318,76.146,81.162,85.304,90.492,94.738,96.923,98.462,101.977,109.263,114.393,119.58,122.516,125.043,130.23,134.562,137.497,142.409,147.596,149.781,151.32,156.887,160.877,165.019,168.98,174.044,176.324,178.50900000000001,180.048,186.309,190.451,192.844,195.371,198.174,203.085,206.572,211.759,214.286,218.428,221.943,224.12800000000001,225.667,228.469,233.381,236.867,239.052,240.591,244.581,249.597,252.124,255.06,257.587,262.774,267.106,269.291,270.83,275.741,280.871,284.358" y="191.91099999999994" svg_rhmargin="286.543" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">Company (Huntington Beach, California) for editing our </text>
  <text x="57.146,64.975,69.117,74.303,79.433,82.806,86.767,90.254,92.781,97.797,100.732" y="203.909" svg_rhmargin="103.012" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">manuscript.</text>
  <text x="57.146,64.817,72.499,80.17,89.117,92.958,98.708,103.814,107.333,115.015,120.121,123.64,127.481,135.151,140.257,147.284,152.39,159.416,165.166" y="233.91200000000003" svg_rhmargin="170.272" style="fill:#171615;font-family:PMDSJO+Frutiger-Black;font-size:11.5px;font-style:NORMAL;font-weight:bold;">Conflict of Interest</text>
  <text x="57.146,62.903,67.967,71.957,74.142,80.061,84.202,89.332,92.268,97.331,102.243,105.729,109.102,111.287,117.205,122.221,126.211,130.173,132.567,136.709,140.195,144.185,146.37,152.289,155.224,160.288,164.43,167.365,169.55,175.469,178.404,183.468,187.458,191.705,193.89000000000001,199.808,204.872,209.014,213.355,217.345,219.53,225.449,230.636,235.547,237.732,243.651,247.612,252.524,260.352,265.368,269.358,272.293,274.82,280.007,284.339" y="251.91200000000003" svg_rhmargin="286.524" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">The authors declare that they have no competing </text>
  <text x="57.146,59.674,64.861,67.796,71.786,75.273,79.263,82.635,85.571,88.943" y="263.91099999999994" svg_rhmargin="91.223" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">interests.</text>
  <text x="57.146,66.093,73.12,78.87,82.711,89.737,94.843,101.87,106.976,110.817,118.499" y="293.912" svg_rhmargin="126.169" style="fill:#171615;font-family:PMDSJO+Frutiger-Black;font-size:11.5px;font-style:NORMAL;font-weight:bold;">Declaration</text>
  <text x="57.146,62.41,65.345,70.409,72.936,76.897,80.27,82.455,83.167,87.309,92.325,97.341,100.827,105.739,110.08,114.222,116.616,118.801,119.514,123.656,128.843,133.859,136.044,136.757,140.718,145.63,150.816,154.189,158.179,163.366,166.301,168.486,169.199,172.135,177.046,179.231,179.944,184.96,189.102,192.588,195.524,198.051,202.012,204.539,209.555,213.697,216.633,220.623,222.903,225.088,225.8,232.84,237.751,240.687,242.872,243.584,247.726,252.742,257.758,260.152,262.679,266.641,270.783,275.675,278.069,282.059,284.339" y="311.912" svg_rhmargin="286.524" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">Ethics approval and consent to participate: Not applicable; </text>
  <text x="57.146,63.407,68.318,73.505,76.878,80.868,86.055,88.99,91.175,94.272,97.075,101.986,105.473,107.658,110.755,115.771,120.901,125.793,128.187,130.714,134.676,138.818,141.753,144.28,149.192,154.379,156.659,158.844,161.941,168.98,173.892,176.827,179.012,182.109,186.251,191.267,196.283,198.677,201.204,205.166,209.308,214.2,216.594,220.584,222.864,225.049,228.146,234.274,238.615,242.757,245.284,247.678,251.82,256.713,259.24,261.634,264.161,267.096,271.343,273.528,276.625,281.536,284.339" y="323.911" svg_rhmargin="286.524" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">Consent for publication: Not applicable; Availability of </text>
  <text x="57.146,62.162,66.304,69.24,73.382,75.56700000000001,77.328,81.47,86.657,91.673,93.858,95.621,103.449,107.591,110.526,114.516,118.003,120.53,124.672,127.066,129.346,131.531,133.293,139.42,141.814,144.208,146.393,148.155,153.171,157.313,160.248,164.39,166.575,168.337,172.669,176.659,181.846,185.836,189.323,193.465,196.4,200.39,205.406,207.591,209.354,214.265,217.752,219.937,221.698,225.84,231.027,235.169,237.563,241.809,245.714,249.704,254.72,256.905,258.667,263.683,268.813,272.3,274.827,280.014,284.346" y="335.909" svg_rhmargin="286.531" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">data and material: All data generated or analyzed during </text>
  <text x="57.146,60.082,65.146,67.673,71.045,73.23,75.415,78.787,81.723,86.853,91.869,96.115,98.3,100.485,104.627,108.114,112.104,114.289,116.474,119.001,124.188,128.15,130.544,135.674,140.69,144.68,149.696,151.881,154.066,156.593,161.78,163.965,166.15,171.166,176.296,181.188,183.582,186.109,189.482,194.545,198.535,203.551,205.736,207.921,212.063,215.55,218.485,221.012,224.974,227.368,231.358" y="347.908" svg_rhmargin="233.638" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">this study are included in published article.</text>
  <text x="57.146,62.951,68.233,71.929,77.211,80.906,86.188,91.993,96.211,101.493" y="370.404" svg_rhmargin="105.711" style="fill:#171615;font-family:HACWBE+FrutigerBold;font-size:9.5px;font-style:NORMAL;font-weight:bold;">References</text>
  <text y="387.912" svg_rhmargin="253.164" x="61.521,65.721,67.821,69.834,72.144,78.855,83.58,87.395,92.173,96.163,98.263,100.27600000000001,102.288,108.999,111.099,113.199,115.212,117.224,120.111,122.211,124.224,126.236,130.883,133.21,137.935,140.035,142.048,144.06,150.579,152.679,154.692,156.704,164.518,168.193,172.97,176.96,179.06,181.073,183.085,186.9,191.678,196.298,198.311,200.323,206.465,208.565,210.578,212.59,219.074,221.401,226.126,228.227,230.24,232.251,236.451,240.651,244.851,249.051,251.151" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">1. Huang, H., J. Liu, Q. Meng, and G. Niu. 2015. </text>
  <text x="72.144,79.958,84.683,86.888,89.591,91.919,96.539,99.75,104.475,108.465,110.47800000000001,112.49,115.701,119.377,122.483,124.81,127.916,130.62,134.435,139.213,142.861,146.536,148.549,150.561,155.181,158.393,162.916,165.62,169.295,171.623,176.4,178.413,180.425,184.24,189.018,193.638,195.651,197.663,200.366,204.89,209.51,214.034,216.361,219.468,223.991,231.201,234.876,238.088,241.903,245.009,248.684,250.697,252.709,256.909,258.92199999999997,260.934,264.749,266.954,271.574,276.238,280.053" y="399.664" svg_rhmargin="282.066" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">Multidrug resistance protein and topoisomerase 2 alpha </text>
  <text x="72.144,75.819,79.923,84.543,87.754,91.429,94.535,97.642,99.969,104.493,109.27,111.283,113.295,115.623,120.4,122.41300000000001,124.425,129.203,133.727,138.504,141.698,141.698,144.804,152.014,155.829,158.034,160.239,162.252,164.264,167.913,171.588,173.793,175.998,178.011,180.023,182.228,186.953,191.73,195.72,197.733,199.745,203.394,207.209,211.986,215.635,219.31,222.521,224.534,226.546,230.361,233.573,237.248,239.261,241.273,244.484,248.159,250.364,254.179,256.883,260.558,265.178" y="411.415" svg_rhmargin="267.191" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">expression in non- small cell lung cancer are related </text>
  <text x="72.144,78.077,80.404,83.108,87.772,89.78500000000001,91.797,96.303,99.514,103.329,105.657,110.434,112.447,114.459,121.669,125.344,128.048,131.863,134.969,137.673,141.488,144.594,146.922,150.028,152.041,154.053,158.673,163.197,166.303,169.007,173.53,178.15,181.825,185.036,188.851,191.555,193.883,197.881,201.556,203.761,207.673,209.773,211.786,213.798,216.738,221.515,224.219,226.319,228.332,230.344,233.231,235.331,237.344,239.356,245.123,247.328,249.655,254.433,256.533,258.546,260.558,265.405,269.509,274.129,276.229" y="423.166" svg_rhmargin="278.242" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">with brain metastasis postoperatively. Int. J. Clin. Exp. </text>
  <text x="72.144,77.027,80.842,83.545,88.209,92.733,94.938,97.038,99.051,101.063,105.263,107.363,111.563,115.763,119.963,124.163,128.363,132.738,136.938,141.138,145.338,149.538,153.738" y="434.917" svg_rhmargin="155.838" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">Pathol. 8:11537–11542.</text>
  <text y="446.669" svg_rhmargin="282.171" x="61.522,65.722,67.822,69.83500000000001,72.144,77.272,81.087,83.414,85.514,87.527,89.539,95.682,97.782,99.795,101.807,107.249,109.349,111.449,113.462,115.474,118.362,120.462,122.47500000000001,124.487,129.614,131.714,133.727,135.739,141.383,146.16,148.26,150.273,152.285,157.492,159.592,161.60500000000002,163.617,169.383,174.047,178.772,180.872,182.88500000000002,184.897,190.558,192.658,194.671,196.683,201.889,203.989,206.002,208.014,216.274,220.089,224.867,228.857,230.957,232.97,234.982,239.147,241.247,243.26000000000002,245.272,253.085,255.185,257.198,259.21,263.857,266.184,268.284,270.29699999999997,272.309,278.058,280.158" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">2. Bai, G. R., J. B. An, Y. Chu, X. Y. Wang, S. M. Li, K. </text>
  <text x="72.144,75.032,77.132,79.14500000000001,81.157,86.363,90.178,94.955,97.055,99.06800000000001,101.08,104.755,107.459,109.47200000000001,111.484,115.299,117.504,119.604,121.617,123.629,127.829,132.029,136.229,140.429,142.529,144.542,146.554,152.32,156.844,164.054,168.674,172.489,175.7,178.028,181.134,185.658,190.435,192.448,194.46,198.984,201.565,203.578,205.59,208.294,212.958,216.633,218.64600000000002,220.658,224.333,226.914,229.495,233.17,236.819,239.523,241.85,245.849,249.524,254.302,257.977,261.083,264.189,266.202,268.214,272.738,275.319" y="458.42" svg_rhmargin="277.332" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">J. Yan, et al. 2016. Comparison of the effectiveness of </text>
  <text x="72.144,78.077,82.74,87.264,89.469,93.144,96.338,96.338,100.844,104.055,107.87,110.198,114.975,116.988,119.0,122.212,126.027,130.646,132.974,137.498,140.201,144.865,148.54,151.751,155.566,160.186,164.098,166.11100000000002,168.123,172.743,174.948,179.673,182.779,184.792,186.804,189.508,193.183,200.393,204.916,208.513,213.036,215.241,219.765,226.975,229.303,233.923,237.598,239.61100000000002,241.623,245.621,249.296,252.508,255.614,260.339,263.445" y="470.171" svg_rhmargin="265.458" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">whole- brain radiotherapy plus temozolomide versus </text>
  <text x="72.144,78.077,82.74,87.264,89.469,93.144,96.338,96.338,100.844,104.055,107.87,110.198,114.975,116.988,119.0,122.212,126.027,130.646,132.974,137.498,140.201,144.865,148.54,151.751,155.566,160.186,164.098,166.11100000000002,168.123,170.45,175.228,177.241,179.253,181.956,185.168,188.843,192.658,195.361,197.689,202.466,206.456,208.469,210.481,214.988,218.199,222.014,224.341,229.119,231.132,233.144,240.354,244.029,246.733,250.548,253.654,256.358,260.173,263.279,266.954,270.06" y="481.922" svg_rhmargin="272.073" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">whole- brain radiotherapy in treating brain metastases </text>
  <text x="72.144,76.65,80.465,83.572,87.247,91.867,93.88000000000001,95.892,100.415,105.193,107.206,109.218,113.033,115.046,117.058,120.164,124.075,127.182,129.885,133.56,140.77,144.585,147.289,149.617,153.265,155.278,157.29,160.501,164.176,168.175,170.503,174.178,180.11,182.12300000000002,184.135,188.659,191.24,193.25300000000001,195.265,198.476,202.291,207.069,211.689,216.213,223.423,225.75,229.346,233.021,237.641,239.654,241.666,245.315,249.839,254.616,257.32,260.531,265.055,267.26,269.465,273.14,277.76" y="493.674" svg_rhmargin="279.773" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">based on a systematic review of randomized controlled </text>
  <text x="72.144,74.848,78.059,80.387,84.202,86.407,89.513,91.613,93.626,95.638,101.282,106.059,108.763,111.09,114.739,118.554,123.332,126.98,130.655,133.867,135.88,137.891,144.27,147.481,152.206,156.197,159.303,161.316,163.328,167.528,171.728,173.828,178.028,182.403,186.603" y="505.425" svg_rhmargin="188.703" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">trials. Anticancer Drugs 27:1–8.</text>
  <text y="517.1759999999999" svg_rhmargin="253.418" x="61.522,65.722,67.822,69.83500000000001,72.144,76.309,78.637,82.312,87.089,90.904,93.004,95.01700000000001,97.029,101.194,103.294,105.394,107.40700000000001,109.419,114.065,116.165,118.17800000000001,120.19,125.957,129.168,131.495,136.273,140.797,142.897,144.91,146.922,154.735,156.835,158.848,160.86,167.239,171.054,175.832,180.355,184.354,188.169,190.269,192.282,194.294,198.459,200.559,202.572,204.584,210.963,214.638,216.843,218.856,220.868,225.75,228.962,232.637,235.34,239.015,241.115,243.12800000000001,245.14,249.305,251.405" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">3. Siena, S., L. Crino, M. Danova, S. Del Prete, S. </text>
  <text x="72.144,77.91,81.725,84.832,88.48,90.808,95.585,100.31,102.41,104.423,106.435,110.6,112.7,114.71300000000001,116.725,120.89,124.705,126.91,130.909,134.724,138.714,143.492,145.819,147.919,149.93200000000002,151.944,155.619,158.323,160.336,162.348,166.163,168.368,170.468,172.481,174.493,178.693,182.893,187.093,191.293,193.393,195.406,197.418,203.797,208.32,211.426,215.102,218.295,218.295,222.915,226.59,231.368,234.474,238.149" y="528.927" svg_rhmargin="240.162" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">Cascinu, S. Salvagni, et al. 2010. Dose- dense </text>
  <text x="72.144,74.848,78.523,85.733,90.257,93.853,98.377,100.582,105.105,112.315,114.643,119.263,122.938,124.95100000000001,126.963,130.174,133.849,137.839,140.167,147.377,151.052,155.829,157.842,159.854,162.435,166.959,170.17,172.183,174.195,176.899,181.563,185.238,187.251,189.263,191.967,195.178,198.853,202.668,205.372,212.582,216.257,221.034,223.738,225.751,227.763,232.287,234.868,236.881,238.893,243.399,246.61,250.425,252.753,257.53" y="540.679" svg_rhmargin="259.543" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">temozolomide regimen for the treatment of brain </text>
  <text x="72.144,79.354,83.029,85.733,89.548,92.654,95.358,99.173,102.279,105.954,109.06,111.07300000000001,113.085,115.667,118.878,123.402,130.612,132.625,134.637,141.847,145.522,147.727,151.542,156.319,160.843,168.053,171.868,173.968,175.981,177.993,182.499,185.71,189.385,193.2,196.307,199.01,201.023,203.035,206.684,210.499,215.277,218.925,222.6,225.812,227.912,229.925,231.937,236.46,239.672,241.685,243.697,245.902,250.627,255.404,259.394" y="552.4300000000001" svg_rhmargin="261.407" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">metastases from melanoma, breast cancer, or lung </text>
  <text x="72.144,75.793,79.608,84.385,88.034,91.709,94.92,96.933,98.945,103.723,108.247,110.95,112.96300000000001,114.975,118.79,126.0,129.675,134.453,138.268,142.774,144.979,148.654,150.667,152.679,155.383,159.907,161.92000000000002,163.932,167.038,171.763,174.974,178.964,182.639,185.85,189.762,191.775,193.787,198.31,201.522,203.535,205.547,208.758,212.573,217.193,219.52,224.044,227.15,231.875,235.087,239.077,242.752,245.963,249.874,251.974,253.987,255.999,259.814" y="564.181" svg_rhmargin="261.827" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">cancer not amenable to surgery or radiosurgery: a </text>
  <text x="72.144,79.354,84.079,86.284,88.988,91.315,94.964,98.639,103.417,106.12,109.795,113.007,115.02000000000001,117.032,121.652,126.315,130.13,133.237,136.912,138.925,140.937,143.877,146.817,148.83,150.842,153.948,156.652,161.377,165.997,169.908,172.008,174.02100000000002,176.033,181.677,186.454,191.232,193.332,195.345,197.357,203.875,208.653,212.302,216.825,219.03,221.13,223.143,225.155,229.355,233.555,235.655,239.855,244.055,248.255,252.63,256.83,261.03,265.23" y="575.932" svg_rhmargin="267.33" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">multicenter phase II study. Ann. Oncol. 21:655–661.</text>
  <text y="587.684" svg_rhmargin="273.902" x="61.522,65.722,67.822,69.83500000000001,72.144,77.788,80.492,85.155,88.97,93.748,97.563,100.669,103.775,106.103,110.627,115.352,117.452,119.465,121.477,128.188,130.288,132.388,134.401,136.413,144.227,146.327,148.34,150.352,154.517,158.428,163.205,167.729,172.349,174.677,179.454,183.978,188.703,190.803,192.816,194.828,199.675,201.775,203.788,205.8,213.614,217.429,220.64,224.455,228.445,232.969,237.694,242.314,246.129,250.417,252.744,255.85,257.95,259.96299999999997,261.975,269.789,271.889" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">4. Athanassiou, H., M. Synodinou, E. Maragoudakis, M. </text>
  <text x="72.144,77.027,80.842,84.053,87.868,90.974,95.262,98.937,102.935,106.75,109.078,113.698,116.025,119.132,121.232,123.245,125.257,131.023,133.123,135.136,137.148,142.993,146.668,149.879,152.207,156.197,160.72,163.827,165.927,167.94,169.952,176.33,178.43,180.443,182.455,190.269,192.597,195.703,199.518,201.845,204.05,206.378,210.998,215.522,220.247,222.347,224.36,226.372,230.047,232.75,234.763,236.775,240.59,242.795,244.895,246.90800000000002,248.92,253.12,257.32,261.52,265.72,267.82" y="599.435" svg_rhmargin="269.833" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">Paraskevaidis, C. Verigos, D. Misailidou, et al. 2005. </text>
  <text x="72.144,77.587,81.402,86.179,90.799,95.323,102.533,104.86,108.457,112.132,116.752,118.765,120.777,125.397,130.06,133.875,136.982,140.657,142.67000000000002,144.682,147.622,150.562,152.57500000000002,154.587,157.693,160.397,165.122,169.742,173.653,175.666,177.678,182.202,184.783,186.796,188.808,191.512,195.187,202.397,206.92,210.517,215.04,217.245,221.769,228.979,231.307,235.927,239.602,241.615,243.627,247.442,252.219,256.839" y="611.186" svg_rhmargin="258.852" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">Randomized phase II study of temozolomide and </text>
  <text x="72.144,75.355,79.17,83.79,86.118,90.642,93.345,98.009,101.684,104.895,108.71,113.33,117.242,119.25500000000001,121.267,124.915,129.439,136.649,141.269,145.084,148.295,151.97,156.59,158.603,160.615,166.548,168.875,171.579,176.243,178.256,180.268,183.479,187.294,191.914,194.242,198.765,201.469,206.133,209.808,213.019,216.834,221.454,225.365,227.37800000000001,229.39,233.205,235.41,239.934,244.711,248.386,250.399,252.411,254.739,259.516,261.529,263.541,268.319,271.994,277.926,280.131,284.043" y="622.937" svg_rhmargin="286.056" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">radiotherapy compared with radiotherapy alone in newly </text>
  <text x="72.144,76.764,79.092,82.907,86.897,91.674,96.198,99.304,102.979,107.599,109.61200000000001,111.624,115.614,117.819,120.147,124.67,129.177,131.382,135.197,138.303,141.007,145.53,152.74,156.555,158.568,160.58,167.79,172.515,174.72,177.424,179.752,182.333,186.857,190.068,197.278,200.953,203.053,205.066,207.078,209.965,212.065,214.078,216.09,221.857,224.062,226.389,231.167,233.267,235.28,237.292,243.81,248.588,252.237,256.76,258.965,261.065" y="634.689" svg_rhmargin="263.078" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">diagnosed glioblastoma multiforme. J. Clin. Oncol. </text>
  <text x="72.144,76.344,80.544,82.644,86.844,91.044,95.244,99.444,103.819,108.019,112.219,116.419,120.619" y="646.44" svg_rhmargin="122.719" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">23:2372–2377.</text>
  <text y="658.191" svg_rhmargin="263.743" x="61.522,65.722,67.822,69.83500000000001,72.144,78.663,81.769,84.473,88.148,91.359,98.569,102.384,107.162,111.939,114.039,116.052,118.064,122.229,124.329,126.429,128.442,130.454,136.22,138.32,140.333,142.345,148.112,151.218,155.033,157.264,161.552,165.367,167.467,169.48000000000002,171.492,176.794,178.894,180.907,182.919,188.047,192.772,196.42,198.625,200.953,205.73,207.83,209.84300000000002,211.855,216.02,218.12,220.133,222.145,226.792,230.467,234.378,238.377,241.588,245.403,248.999,251.099,253.112,255.124,259.63,261.73" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">5. Ostermann, S., C. Csajka, T. Buclin, S. Leyvraz, F. </text>
  <text x="72.144,76.79,80.465,82.697,86.372,91.097,95.874,99.549,101.649,103.662,105.674,110.32,112.42,114.433,116.445,122.089,124.189,126.202,128.214,134.593,138.268,141.917,146.44,149.546,152.25,155.925,159.136,163.756,165.856,167.869,169.881,173.556,176.26,178.273,180.285,184.1,186.305,188.405,190.418,192.43,196.63,200.83,205.03,209.23,211.33,213.34300000000002,215.355,220.238,222.443,226.258,229.364,236.574,240.389,242.40200000000002,244.414,248.229,253.006,257.626" y="669.942" svg_rhmargin="259.639" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">Lejeune, L. A. Decosterd, et al. 2004. Plasma and </text>
  <text x="72.144,75.793,79.468,82.679,86.354,90.86,94.072,98.595,101.702,106.322,108.649,113.427,117.242,119.447,121.46000000000001,123.472,128.258,132.983,135.31,139.93,141.943,143.955,148.575,153.099,157.719,162.444,164.649,168.464,171.168,173.495,178.019,182.797,184.81,186.822,191.441,196.105,199.92,203.132,210.342,214.157,217.805,222.329,226.617,228.944,233.722,237.397,240.1,242.428,246.077,249.183,251.196,253.208,257.732,260.313" y="681.694" svg_rhmargin="262.326" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">cerebrospinal fluid population pharmacokinetics of </text>
  <text x="72.144,74.848,78.523,85.733,90.257,93.853,98.377,100.582,105.105,112.315,114.643,119.263,122.938,124.95100000000001,126.963,129.29,134.068,136.08100000000002,138.093,145.303,149.118,151.323,153.65,157.64,162.418,166.233,171.01,173.714,175.727,177.739,181.729,183.934,186.262,190.785,197.995,201.81,203.823,205.835,210.455,214.27,216.974,219.302,222.977,227.754,230.458,233.564,235.664,237.677,239.689,245.455,247.66,249.988,254.765,256.865" y="693.4449999999999" svg_rhmargin="258.878" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">temozolomide in malignant glioma patients. Clin. </text>
  <text svg_rhmargin="169.986" x="72.144,77.91,81.725,86.503,90.152,93.827,97.038,99.051,101.063,106.505,110.18,113.287,115.387,117.4,119.412,123.612,127.812,129.912,134.112,138.312,142.512,146.712,151.087,155.286,159.486,163.686,167.886,169.986" y="95.38199999999995" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">Cancer Res. 10:3728–3736. </text>
  <text y="95.38199999999995" svg_rhmargin="523.706" x="306.854,311.054,313.154,315.167,317.477,323.243,327.906,332.632,336.447,338.547,340.56,342.572,348.95,351.05,353.15,355.16299999999995,357.175,364.989,367.089,369.102,371.114,376.863,380.074,383.67,387.485,391.773,396.297,402.229,405.335,409.623,411.95,414.05,416.063,418.075,423.842,425.942,427.955,429.967,435.733,440.397,444.92,449.645,453.46,455.788,460.408,462.508,464.52099999999996,466.533,474.347,476.447,478.46,480.472,486.614,488.714,490.727,492.739,497.622,501.437,503.642,505.846,510.37,513.074,515.778,519.593,521.693" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">6. Chua, D., M. Krzakowski, C. Chouaid, M. G. Pallotta, </text>
  <text x="317.477,320.364,322.464,324.477,326.489,329.429,331.529,333.542,335.554,343.368,347.183,350.394,353.098,355.425,360.203,363.878,367.474,369.574,371.587,373.599,381.413,383.513,385.52599999999995,387.538,393.68,398.204,400.908,403.611,406.193,409.404,411.731,415.406,420.026,422.126,424.13899999999995,426.151,429.826,432.53,434.54299999999995,436.555,440.37,442.575,444.675,446.688,448.7,452.9,457.1,461.3,465.5,467.6,469.613,471.625,479.885,484.549,489.073,491.278,494.953,498.146,498.147,502.653,505.864,509.679,512.007,516.784" y="107.13400000000001" svg_rhmargin="518.797" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">J. I. Martinez, M. Gottfried, et al. 2010. Whole- brain </text>
  <text x="317.477,320.688,324.503,329.123,331.45,335.265,337.969,340.297,344.82,349.598,351.611,353.623,356.326,360.99,364.665,367.876,371.691,376.311,380.223,382.236,384.248,388.868,391.073,395.798,398.904,400.917,402.929,406.578,411.101,415.879,419.528,424.051,431.261,433.589,436.293,440.108,444.885,447.589,449.602,451.614,454.318,457.993,465.203,469.726,473.323,477.846,480.051,484.575,491.785,494.113,498.733,502.408,504.421,506.433,509.014,513.538,516.749" y="118.88499999999999" svg_rhmargin="518.762" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">radiation therapy plus concomitant temozolomide for </text>
  <text x="317.477,320.18,324.844,328.519,330.532,332.544,335.248,338.459,342.134,345.949,348.653,355.863,359.538,364.315,367.019,369.032,371.044,375.568,378.149,380.162,382.174,386.68,389.891,393.706,396.034,400.811,402.82399999999996,404.836,412.046,415.721,418.425,422.24,425.346,428.05,431.865,434.971,438.646,441.753,443.76599999999996,445.778,448.359,451.57,456.094,463.304,465.31699999999995,467.329,472.106,476.63,481.408,484.601,484.602,487.708,494.918,498.733,500.938,503.143,506.336,506.336,509.985,513.66,515.865,518.07" y="130.63599999999997" svg_rhmargin="520.083" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">the treatment of brain metastases from non- small- cell </text>
  <text x="317.477,319.681,324.406,329.184,333.174,335.18699999999995,337.199,340.848,344.663,349.44,353.089,356.764,359.975,362.075,364.08799999999997,366.1,369.915,371.928,373.94,377.151,380.966,385.744,390.364,394.888,402.098,404.425,408.021,411.696,416.316,418.416,420.429,422.441,426.965,431.585,435.26,440.038,443.231,443.232,445.436,449.251,453.758,457.433,459.638,461.65099999999995,463.663,468.283,472.946,476.761,479.868,483.543,485.556,487.568,490.508,493.448,495.46099999999996,497.473,500.579,503.283,508.008,512.628,516.539,518.639" y="142.38699999999994" svg_rhmargin="520.652" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">lung cancer: a randomized, open- label phase II study. </text>
  <text x="317.477,323.243,325.448,327.775,332.553,334.653,336.666,338.678,343.324,348.049,352.826,356.816,358.82899999999995,360.841,366.608,370.423,375.2,378.849,382.524,385.735,387.748,389.76,393.96,398.16,400.26,404.46,408.66,412.86,417.235,421.435,425.635,429.835" y="154.139" svg_rhmargin="431.935" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">Clin. Lung Cancer 11:176–181.</text>
  <text y="165.89" svg_rhmargin="523.924" x="306.854,311.054,313.154,315.167,317.477,322.123,324.45,326.55,328.563,330.575,336.954,341.478,346.203,350.823,355.346,360.072,362.172,364.185,366.197,371.438,376.102,380.827,385.35,387.931,391.606,393.934,395.947,397.959,403.086,405.414,407.514,409.527,411.539,416.745,420.56,425.338,430.001,434.727,437.054,439.06699999999995,441.079,443.967,446.294,450.109,454.887,458.877,460.977,462.98999999999995,465.002,468.817,473.594,478.214,480.227,482.239,487.445,489.773,496.983,499.31,504.088,506.101,508.113,512.759,515.087,519.812,521.911" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">7. Li, Doudou, Zhuofei Bi, Yanhui Jiang, and Yimin Liu. </text>
  <text x="317.477,321.677,325.877,330.077,334.277,336.377,338.39,340.402,345.249,347.83,350.412,354.087,357.735,360.439,362.452,364.464,368.988,371.569,373.582,375.594,381.526,386.19,390.714,392.919,396.594,398.60699999999997,400.619,405.125,408.336,412.151,414.479,419.256,421.26899999999995,423.281,426.493,430.308,434.928,437.255,441.779,444.483,449.146,452.821,456.033,459.848,464.468,468.379,470.392,472.404,476.053,480.576,487.786,492.293,494.62,499.398,503.073,507.693,509.70599999999996,511.718,517.65,519.978,522.681,527.345" y="177.64099999999996" svg_rhmargin="529.358" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">2015. Effect of whole brain radiotherapy combined with </text>
  <text x="317.477,320.18,323.855,331.065,335.589,339.185,343.709,345.914,350.438,357.648,359.975,364.595,368.27,370.28299999999996,372.295,374.623,379.4,381.41299999999995,383.425,386.129,390.793,394.468,396.481,398.493,401.196,404.408,408.083,411.898,414.601,421.811,425.486,430.264,432.968,434.981,436.993,441.516,444.098,446.111,448.123,452.629,455.84,459.655,461.983,466.76,468.77299999999997,470.785,477.995,481.67,484.374,488.189,491.295,493.999,497.814,500.92,503.248,506.354,508.36699999999996,510.379,514.903,517.484" y="189.39200000000005" svg_rhmargin="519.497" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">temozolomide in the treatment of brain metastasis of </text>
  <text x="317.477,322.254,326.778,331.555,334.749,334.749,337.855,345.065,348.88,351.085,353.29,355.303,357.315,360.964,364.639,366.844,369.049,371.06199999999995,373.074,375.279,380.004,384.781,388.771,390.784,392.796,396.445,400.26,405.038,408.686,412.361,415.573,417.673,419.686,421.698,427.84,432.565,436.38,441.158,445.148,449.768,454.291,459.069,463.059,465.072,467.084,474.898,478.573,483.193,485.293,487.306,489.318,492.205,494.305" y="201.14300000000003" svg_rhmargin="496.318" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">non- small cell lung cancer. Guangdong Med. J. </text>
  <text x="317.477,321.677,325.877,327.977,332.177,336.377,340.577,344.777,349.152,353.352,357.552,361.752,365.952" y="212.89499999999998" svg_rhmargin="368.052" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">36:1534–1536.</text>
  <text y="224.64599999999996" svg_rhmargin="528.229" x="306.854,311.054,313.154,315.167,317.477,324.188,326.515,330.505,334.495,336.823,341.6,344.707,346.807,348.82,350.832,353.719,355.819,357.832,359.844,364.727,366.827,368.84,370.852,376.154,378.254,382.419,384.519,386.532,388.544,394.687,397.898,401.573,405.248,410.025,412.03799999999995,414.05,417.288,420.963,425.583,428.689,431.926,434.026,436.039,438.051,443.818,448.341,451.99,456.654,459.865,463.68,468.458,472.133,474.14599999999996,476.158,480.821,484.636,489.414,494.034,498.54,503.064,507.588,511.875,513.888,515.9,518.481,523.005,526.216" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">8. Higgins, J. P. T.S. Green (eds). Cochrane handbook for </text>
  <text x="317.477,320.583,324.494,327.6,330.304,333.979,341.189,345.004,347.708,350.035,353.684,355.697,357.709,360.92,364.595,368.594,370.921,374.596,380.529,383.635,385.64799999999997,387.66,392.184,394.765,396.77799999999996,398.79,401.118,405.895,408.599,412.274,415.485,419.484,423.159,427.936,430.64,432.968,437.491,442.269,445.375,447.388,449.4,453.399,457.074,460.285,463.391,465.719,470.243,475.02,477.03299999999996,479.045,483.245,485.345,489.545,491.645,495.845" y="236.39700000000005" svg_rhmargin="497.858" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">systematic reviews of interventions version 5.0.0 </text>
  <text x="317.477,320.714,325.439,330.059,334.679,338.494,341.198,344.873,349.493,351.506,353.518,358.024,361.699,366.205,369.416,374.141,377.956,381.168,385.079,387.092,389.104,393.304,397.504,401.704,405.904,409.141,411.154,413.166,416.404,421.251,426.379,429.179,435.698,440.344,443.581,445.681,447.69399999999996,449.706,452.944,457.144,461.344,465.544,469.744,472.938,477.138,481.338,484.531,488.732,491.969,494.069,496.082,498.094,502.758,505.461,508.165,512.785,514.885,517.685" y="248.14800000000002" svg_rhmargin="520.485" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">(updated February 2008) [EB/OL]. [2008-07-7]. http://</text>
  <text x="317.477,323.409,329.341,335.274,337.374,341.023,345.546,349.195,353.859,357.07,360.885,365.663,367.676,369.688,373.363,378.026,381.841,386.619,391.239,395.745,400.269,404.793,409.08" y="259.9" svg_rhmargin="411.18" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">www.cochran ehandbook.</text>
  <text y="271.65099999999995" svg_rhmargin="490.325" x="306.854,311.054,313.154,315.167,317.477,320.417,324.94,328.755,333.533,338.31,340.638,345.258,347.585,350.692,352.792,354.80499999999995,356.817,359.704,361.804,363.81699999999995,365.829,370.712,372.812,374.912,376.92499999999995,378.937,382.752,387.529,392.149,394.162,396.174,402.658,404.758,406.77099999999996,408.783,414.427,416.527,418.53999999999996,420.552,425.434,429.249,431.953,435.059,439.583,444.203,448.727,453.452,455.657,460.18,463.287,465.387,467.4,469.412,473.612,477.812,482.012,486.212,488.312" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">9. Ioannidis, J. P., and N. A. Patsopoulos. 2007. </text>
  <text x="317.477,323.855,328.633,332.281,335.956,339.168,341.871,345.686,348.014,352.791,355.495,359.406,361.419,363.431,365.759,370.536,372.549,374.561,379.225,382.9,385.604,389.279,392.49,397.014,401.004,404.679,409.456,413.131,415.459,418.163,422.074,424.087,426.099,429.774,432.88,435.584,437.911,445.121,448.936,451.64,455.315,458.421,460.43399999999997,462.446,464.774,469.551,471.56399999999996,473.576,480.786,484.461,487.165,490.98,494.174,494.174,497.989,502.767,506.582,508.786,512.698,515.804,519.479,522.585,524.685" y="283.40200000000004" svg_rhmargin="526.698" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">Uncertainty in heterogeneity estimates in meta- analyses. </text>
  <text x="317.477,322.604,330.418,333.305,335.318,337.33,341.53,345.73,349.93,352.03,356.23,360.43,364.63,369.005,373.205,377.405,381.605" y="295.153" svg_rhmargin="383.705" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">BMJ 335:914–916.</text>
  <text x="302.479,306.679,310.879,312.979,314.99199999999996,317.477,323.12,327.74,332.36,336.035,340.559,342.659,344.67199999999997,346.684,352.126,354.226,356.326,358.339,360.351,366.118,368.218,370.231,372.243,378.621,382.296,384.30899999999997,386.321,391.764,396.288,399.394,403.209,405.309,407.322,409.334,415.179,417.279,419.292,421.304,425.81,429.625,431.953,436.476,438.681,442.496,444.596,446.609,448.621,453.268,455.368,457.381,459.393,464.039,467.714,472.238,474.338,476.351,478.363,484.505,486.605,488.618,490.63,496.396,500.071,504.849,509.626,513.441,520.651,525.175,527.275" y="306.904" svg_rhmargin="529.288" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">10. Addeo, R., C. De Rosa, V. Faiola, L. Leo, G. Cennamo, </text>
  <text x="317.477,322.123,324.223,326.236,328.248,336.061,340.585,345.363,348.066,351.741,353.946,356.151,359.966,362.066,364.07899999999995,366.091,369.766,372.47,374.483,376.495,380.31,382.515,384.615,386.628,388.64,392.84,397.04,401.24,405.44,407.54,409.553,411.565,416.448,421.111,424.926,428.033,431.708,433.721,435.733,439.933,441.94599999999997,443.958,446.661,449.873,452.2,456.015,458.22,460.233,462.245,466.769,469.35,471.363,473.375,476.079,479.754,486.964,491.488,495.084,499.608,501.813,506.336,513.546,515.874,520.494,524.169" y="318.656" svg_rhmargin="526.182" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">L. Montella, et al. 2008. Phase 2 trial of temozolomide </text>
  <text x="317.477,322.202,325.308,327.635,332.413,336.403,338.416,340.428,345.048,348.259,352.783,355.486,358.698,362.513,366.161,368.865,372.54,377.16,379.173,381.185,383.39,387.914,393.846,397.04,397.04,401.66,406.184,409.29,412.965,414.97799999999995,416.99,420.805,425.583,430.203,432.21599999999995,434.228,440.16,444.824,449.348,451.553,455.228,458.421,458.422,462.928,466.139,469.954,472.282,477.059,479.072,481.084,484.295,488.11,492.73,495.058,499.582,502.285,506.949,510.624,513.835,517.65,522.27,526.182" y="330.407" svg_rhmargin="528.195" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">using protracted low- dose and whole- brain radiotherapy </text>
  <text x="317.477,320.058,324.581,327.793,329.806,331.818,336.595,341.119,345.896,349.003,356.213,360.028,362.233,364.438,366.45099999999996,368.463,372.111,375.786,377.991,380.196,382.209,384.221,386.426,391.151,395.929,399.919,401.93199999999996,403.944,407.593,411.408,416.185,419.834,423.509,426.72,428.733,430.745,434.56,439.338,443.958,445.971,447.983,452.489,455.7,459.375,463.19,466.296,469.0,471.013,473.025,476.674,480.489,485.266,488.915,492.59,495.801,497.81399999999996,499.826,504.446,508.261,510.965,513.292,516.967,521.745,524.449,527.555" y="342.158" svg_rhmargin="529.568" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">for nonsmall cell lung cancer and breast cancer patients </text>
  <text x="317.477,323.409,325.737,328.44,333.104,335.11699999999996,337.129,341.635,344.846,348.661,350.989,355.767,357.78,359.792,367.001,370.676,373.38,377.195,380.301,383.005,386.82,389.926,393.601,396.708,398.808,400.82099999999997,402.833,408.599,412.414,417.191,420.84,424.515,427.726,429.739,431.751,435.951,440.151,444.351,446.451,450.651,454.852,459.052,463.252,467.627,471.827,476.027,480.227,484.427" y="353.909" svg_rhmargin="486.527" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">with brain metastases. Cancer 113:2524–2531.</text>
  <text x="302.479,306.679,310.879,312.979,314.99199999999996,317.477,323.243,327.766,330.978,333.681,338.205,340.909,343.009,345.022,347.034,352.678,354.778,356.791,358.803,363.93,366.03,368.13,370.143,372.155,376.801,378.901,380.914,382.926,389.069,392.744,395.955,398.283,403.06,405.388,409.063,412.274,415.949,418.049,420.06199999999995,422.074,428.216,430.316,432.32899999999995,434.341,439.784,444.308,448.814,451.141,455.919,459.594,462.298,464.398,466.411,468.423,471.31,473.41,475.423,477.435,482.081,484.181,486.19399999999996,488.206,493.334,496.545,500.22,502.924,507.448,512.225,514.325,516.3380000000001,518.35,523.793,525.893" y="365.661" svg_rhmargin="527.906" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">11. Cortot, A. B., L. Geriniere, G. Robinet, J. L. Breton, R. </text>
  <text x="317.477,323.243,327.766,330.978,334.189,337.864,339.964,341.977,343.989,348.635,350.735,352.748,354.76,359.266,363.081,365.286,368.935,373.599,377.274,380.485,385.009,387.109,389.12199999999996,391.134,394.809,397.513,399.52599999999995,401.538,405.353,407.558,409.658,411.671,413.683,417.883,422.083,426.283,430.483,432.583,434.596,436.608,441.49,446.154,449.969,453.075,456.75,458.763,460.775,463.715,466.655,468.66799999999995,470.68,473.384,476.595,478.923,482.738,484.943,486.95599999999996,488.968,493.491,496.073" y="377.412" svg_rhmargin="498.086" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">Corre, L. Falchero, et al. 2006. Phase II trial of </text>
  <text x="317.477,320.18,323.855,331.065,335.589,339.185,343.709,345.914,350.438,357.648,359.975,364.595,368.27,370.28299999999996,372.295,376.11,380.888,385.508,387.52099999999996,389.533,393.181,395.509,398.615,403.235,405.44,409.255,411.959,414.286,419.064,421.077,423.089,425.67,430.194,432.399,434.604,439.128,445.06,448.735,453.355,455.368,457.38,461.886,465.798,467.811,469.823,475.755,480.419,484.943,487.148,490.823,492.83599999999996,494.848,499.354,502.565,506.38,508.708,513.485" y="389.163" svg_rhmargin="515.498" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">temozolomide and cisplatin followed by whole brain </text>
  <text x="317.477,320.688,324.503,329.123,331.45,335.974,338.678,343.341,347.016,350.228,354.043,358.663,362.574,364.587,366.599,368.926,373.704,375.717,377.729,382.506,387.03,391.808,395.001,395.001,398.108,405.318,409.133,411.338,413.543,416.736,416.737,420.385,424.06,426.265,428.47,430.483,432.495,434.7,439.425,444.203,448.193,450.20599999999996,452.218,455.866,459.681,464.459,468.108,471.783,474.994,477.007,479.019,483.639,487.454,490.158,492.485,496.16,500.938,503.641,506.748,508.76099999999997,510.773,516.705,519.033,521.736,526.4" y="400.914" svg_rhmargin="528.413" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">radiotherapy in non- small- cell lung cancer patients with </text>
  <text x="317.477,321.983,325.194,329.009,331.337,336.114,338.12699999999995,340.139,347.349,351.024,353.728,357.543,360.649,363.353,367.168,370.274,373.949,377.055,379.155,381.16799999999995,383.18,386.995,389.008,391.02,397.163,401.809,408.328,413.63,416.824,416.824,422.966,427.473,432.355,438.121,440.13399999999996,442.146,445.253,447.956,452.681,457.301,461.213,463.313,465.32599999999996,467.338,472.981,477.759,482.536,484.636,486.649,488.661,495.18,499.958,503.606,508.13,510.335,512.435" y="412.666" svg_rhmargin="514.448" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">brain metastases: a GLOT- GFPC study. Ann. Oncol. </text>
  <text x="317.477,321.677,325.877,327.977,332.177,336.377,340.577,344.777,349.152,353.352,357.552,361.752,365.952" y="424.417" svg_rhmargin="368.052" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">17:1412–1417.</text>
  <text x="302.479,306.679,310.879,312.979,314.99199999999996,317.477,323.855,327.452,329.779,333.594,338.214,341.81,344.138,348.863,351.969,355.565,359.853,364.377,366.477,368.48999999999995,370.502,375.944,378.044,380.144,382.157,384.169,389.813,391.913,393.926,395.938,401.582,404.793,409.413,411.74,415.337,418.933,423.457,428.234,430.562,432.662,434.67499999999995,436.687,441.569,443.669,445.68199999999996,447.694,452.542,454.642,456.655,458.667,463.549,468.073,471.179,473.883,481.093,485.818,488.924,491.024,493.037,495.049,499.897,501.997,504.01,506.022,510.528,512.628" y="436.168" svg_rhmargin="514.641" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">12. Dziadziuszko, R., A. Ardizzoni, P. E. Postmus, E. F. </text>
  <text x="317.477,321.642,328.852,331.179,333.883,335.983,337.996,340.008,345.651,347.751,349.76399999999995,351.776,356.659,359.87,362.198,365.846,369.521,371.621,373.63399999999996,375.646,381.413,383.513,385.52599999999995,387.538,393.916,397.591,402.098,405.309,410.034,413.945,418.723,422.398,424.498,426.51099999999997,428.523,432.198,434.901,436.914,438.926,442.741,444.946,447.046,449.05899999999997,451.071,455.271,459.471,463.671,467.871,469.971,471.984,473.996,479.299,482.974,490.184,494.708,498.304,502.828,505.033,509.556,516.766,519.094,523.714,527.389" y="447.919" svg_rhmargin="529.402" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">Smit, A. Price, C. Debruyne, et al. 2003. Temozolomide </text>
  <text x="317.477,319.804,324.582,326.59499999999997,328.607,333.227,337.042,339.745,342.073,345.748,350.525,353.229,356.335,358.34799999999996,360.36,366.293,368.62,371.324,375.988,378.001,380.013,383.828,388.448,392.446,396.261,401.039,404.688,408.363,412.983,414.996,417.008,421.785,426.309,431.086,434.28,434.28,437.387,444.596,448.411,450.616,452.821,454.834,456.846,460.495,464.17,466.375,468.58,470.59299999999996,472.605,474.81,479.535,484.313,488.303,490.316,492.328,495.976,499.791,504.569,508.218,511.893,515.104" y="459.671" svg_rhmargin="517.117" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">in patients with advanced non- small cell lung cancer </text>
  <text x="317.477,323.409,325.737,328.44,333.104,335.11699999999996,337.129,340.944,345.721,350.341,352.354,354.366,360.299,362.626,365.33,369.994,374.518,379.243,381.946,383.959,385.971,390.478,393.689,397.504,399.831,404.609,406.62199999999996,408.634,415.844,419.519,422.223,426.038,429.144,431.848,435.663,438.769,442.444,445.55,447.65,449.66299999999995,451.675,455.49,457.503,459.515,464.135,468.799,472.614,475.72,479.395,481.40799999999996,483.42,486.36,489.3,491.313,493.325,496.431,499.135,503.86,508.48,512.391,514.404,516.416,520.94,523.521" y="471.422" svg_rhmargin="525.534" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">with and without brain metastases: a phase II study of </text>
  <text x="317.477,320.18,324.844,328.519,330.532,332.544,337.391,343.91,349.353,354.655,360.421,362.43399999999997,364.446,369.093,373.818,378.595,382.585,384.59799999999996,386.61,392.376,396.191,400.969,404.618,408.293,411.504,413.517,415.529,421.671,424.883,429.406,434.131,438.751,440.76399999999995,442.776,446.014,450.214,454.414,458.614,462.814,467.014,470.251,472.351,474.364,476.376,481.224,485.949,489.16,491.26,493.27299999999997,495.285,498.173,500.273,502.286,504.298,510.064,513.879,518.656,522.305,525.98,529.191" y="483.173" svg_rhmargin="531.204" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">the EORTC Lung Cancer Group (08965). Eur. J. Cancer </text>
  <text x="317.477,321.677,325.877,327.977,332.177,336.377,340.577,344.777,349.152,353.352,357.552,361.752,365.952" y="494.924" svg_rhmargin="368.052" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">39:1271–1276.</text>
  <text x="302.479,306.679,310.879,312.979,314.99199999999996,317.477,322.718,327.382,331.197,335.72,337.82,339.83299999999997,341.845,346.01,348.11,350.123,352.135,355.023,357.123,359.13599999999997,361.148,365.348,369.548,373.748,377.948,380.048,382.061,384.073,389.839,392.044,394.372,399.149,401.477,405.125,408.94,411.145,413.15799999999996,415.17,418.845,421.427,426.213,429.862,433.677,437.325,441.237,443.25,445.262,449.785,452.366,454.37899999999996,456.391,461.694,465.369,472.579,477.103,480.699,485.223,487.428,491.951,499.161,501.489,506.109,509.784" y="506.676" svg_rhmargin="511.797" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">13. Zhao, S. J. 2016. Clinical efficacy of Temozolomide </text>
  <text x="317.477,323.243,327.766,334.976,339.483,341.81,346.588,350.263,354.883,356.89599999999996,358.908,364.84,367.168,369.871,374.535,376.548,378.56,384.493,389.156,393.68,395.885,399.56,401.573,403.585,408.091,411.303,415.118,417.445,422.223,424.236,426.248,429.459,433.274,437.894,440.221,444.745,447.449,452.113,455.788,458.999,462.814,467.434,471.345,473.358,475.37,477.698,482.475,484.488,486.5,489.204,493.868,497.543" y="518.427" svg_rhmargin="499.556" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">Combined with whole brain radiotherapy in the </text>
  <text x="317.477,320.18,323.391,327.066,330.881,333.585,340.795,344.47,349.248,351.951,353.964,355.976,360.5,363.081,365.094,367.106,371.884,376.408,381.185,383.198,385.21,388.316,395.526,399.341,401.546,403.751,405.76399999999995,407.776,411.425,415.1,417.305,419.51,421.52299999999997,423.535,425.74,430.465,435.243,439.233,441.246,443.258,446.906,450.721,455.499,459.147,462.822,466.034,468.04699999999997,470.059,475.991,478.319,481.022,485.686,487.69899999999996,489.711,494.217,497.429,501.244,503.571,508.349" y="530.178" svg_rhmargin="510.362" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">treatment of non small cell lung cancer with brain </text>
  <text x="317.477,324.686,328.361,331.065,334.88,337.986,340.69,344.505,347.611,349.939,353.045,355.145,357.15799999999996,359.17,364.936,369.6,371.928,376.705,378.71799999999996,380.73,383.618,385.631,387.643,393.409,395.614,397.941,402.719,404.73199999999997,406.744,412.186,416.001,418.705,421.033,425.556,430.334,434.149,436.354,438.36699999999996,440.379,446.758,449.969,454.694,458.684,460.697,462.709,469.088,472.194,475.869,477.882,479.894,484.094,486.194,490.394,494.594,498.794,503.169,507.369,511.569,515.769" y="541.9300000000001" svg_rhmargin="517.869" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">metastasis. Chin J Clin Rational Drug Use 9:102–103.</text>
  <text x="302.479,306.679,310.879,312.979,314.99199999999996,317.477,325.29,327.618,332.395,337.173,339.5,342.204,344.532,346.632,348.645,350.657,356.799,358.899,360.999,363.012,365.024,370.79,372.89,374.90299999999996,376.915,381.08,384.729,388.544,391.755,394.083,398.86,402.85,405.178,407.278,409.291,411.303,417.445,419.545,421.558,423.57,428.216,432.031,436.809,440.405,444.08,446.784,449.488,453.303,455.403,457.416,459.428,465.071,467.171,469.18399999999997,471.196,476.324,480.848,484.444,488.04,491.855,496.379,498.479,500.49199999999996,502.504,508.148,510.248" y="553.681" svg_rhmargin="512.261" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">14. Minniti, G., C. Scaringi, G. Lanzetta, A. Bozzao, A. </text>
  <text x="317.477,322.919,327.443,334.653,338.468,343.245,347.769,349.869,351.882,353.894,359.739,361.839,363.852,365.864,372.243,375.918,377.931,379.943,384.108,387.923,392.7,396.349,399.053,401.38,404.486,406.586,408.599,410.611,414.286,416.99,419.003,421.015,424.83,427.035,429.135,431.14799999999997,433.16,437.36,441.56,445.76,449.96,452.06,454.073,456.085,464.345,469.009,473.533,475.738,479.413,481.426,483.438,487.944,491.155,494.97,497.298,502.075" y="565.432" svg_rhmargin="504.088" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">Romano, V. De Sanctis, et al. 2014. Whole brain </text>
  <text x="317.477,320.688,324.363,326.69,329.901,333.113,336.928,341.548,343.875,347.69,350.394,352.721,357.245,362.023,364.036,366.048,369.863,374.64,379.26,381.27299999999997,383.285,386.934,391.458,396.235,399.884,404.609,407.82,411.031,414.706,419.484,422.188,424.20099999999996,426.213,428.916,432.591,439.801,444.325,447.921,452.445,454.65,459.174,466.384,468.711,473.331,477.006,479.01899999999995,481.031,483.359,488.136,490.149,492.161,496.781,500.596,503.3,505.628,509.303,514.08,516.784,519.89" y="577.183" svg_rhmargin="521.903" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">reirradiation and concurrent temozolomide in patients </text>
  <text x="317.477,323.409,325.737,328.44,333.104,335.11699999999996,337.129,341.635,344.846,348.661,350.989,355.767,357.78,359.792,367.001,370.676,373.38,377.195,380.301,383.005,386.82,389.926,393.601,396.708,398.808,400.82099999999997,402.833,405.72,407.82,409.83299999999997,411.845,418.329,422.004,426.729,429.94,434.464,438.988,443.765,447.414,451.938,454.143,456.243,458.256,460.268,464.468,468.668,472.868,474.968,479.168,483.368,487.568,491.943,496.143,500.343,504.543" y="588.935" svg_rhmargin="506.643" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">with brain metastases. J. Neurooncol. 118:329–334.</text>
  <text x="302.479,306.679,310.879,312.979,314.99199999999996,317.477,323.225,327.749,332.474,336.473,340.288,343.499,345.827,348.933,351.033,353.046,355.058,357.945,360.045,362.058,364.07,369.513,371.613,373.713,375.726,377.738,383.382,385.482,387.495,389.507,397.32,399.648,401.853,404.18,407.995,412.615,417.139,421.864,423.964,425.977,427.989,433.834,435.934,437.947,439.959,444.807,446.907,448.91999999999996,450.932,456.68,461.204,465.929,468.134,472.658,477.383,479.588,481.915,485.73,488.837,490.937,492.95,494.962,501.34,503.44" y="600.686" svg_rhmargin="505.453" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">15. Kouvaris, J. R., A. Miliadou, V. E. Kouloulias, D. </text>
  <text x="317.477,323.225,327.749,329.954,334.478,338.765,343.289,348.014,351.225,353.553,356.659,358.759,360.772,362.784,370.598,372.698,374.71099999999996,376.723,379.61,381.71,383.72299999999996,385.735,390.863,394.678,396.883,400.698,403.279,407.803,412.528,415.231,419.046,421.146,423.159,425.171,430.833,432.933,434.94599999999997,436.958,443.441,445.542,447.55499999999995,449.566,454.449,458.264,462.884,466.699,470.348,475.012,478.827,482.038,485.853,488.058,491.873,499.083,503.703,508.226,512.951,516.058,518.158" y="612.437" svg_rhmargin="520.171" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">Kolokouris, M. J. Balafouta, X. N. Papacharalampous, </text>
  <text x="317.477,321.151,323.855,325.868,327.88,331.695,333.9,336.0,338.013,340.025,344.225,348.425,352.625,356.825,358.925,360.938,362.95,367.833,372.497,376.312,379.418,383.093,385.106,387.118,390.058,392.998,395.01099999999997,397.023,400.129,402.833,407.558,412.178,416.089,418.102,420.114,424.638,427.219,429.23199999999997,431.244,433.948,437.623,444.833,449.356,452.953,457.476,459.681,464.205,471.415,473.743,478.363,482.038,484.051,486.063,489.878,494.655,499.275" y="624.188" svg_rhmargin="501.288" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">et al. 2007. Phase II study of temozolomide and </text>
  <text x="317.477,321.125,325.649,330.426,334.075,338.599,345.809,348.136,350.84,354.655,359.433,362.136,364.149,366.161,372.094,376.758,381.281,383.486,387.161,390.355,390.355,394.862,398.073,401.888,404.215,408.993,411.006,413.018,416.229,420.044,424.664,426.992,431.515,434.219,438.883,442.558,445.769,449.584,454.204,458.115,460.128,462.14,464.468,469.245,471.258,473.27,477.89,481.705,484.409,486.736,490.411,495.189,497.893,500.999,503.012,505.024,510.956,513.284,515.988,520.651" y="635.94" svg_rhmargin="522.664" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">concomitant whole- brain radiotherapy in patients with </text>
  <text x="317.477,321.983,325.194,329.009,331.337,336.114,338.12699999999995,340.139,347.349,351.024,353.728,357.543,360.649,363.353,367.168,370.274,373.949,377.055,379.068,381.08,383.661,386.873,391.396,398.606,400.61899999999997,402.631,405.738,410.261,412.466,414.794,419.414,421.42699999999996,423.439,426.143,430.868,438.078,442.601,445.813,448.919,451.019,453.032,455.044,461.563,466.34,470.628,475.151,477.356,481.88,485.87,488.198,491.873" y="647.691" svg_rhmargin="493.886" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">brain metastases from solid tumors. Onkologie </text>
  <text x="317.477,321.677,325.877,327.977,332.177,336.377,340.577,344.952,349.152,353.352,357.552" y="659.442" svg_rhmargin="359.652" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">30:361–366.</text>
  <text x="302.479,306.679,310.879,312.979,314.99199999999996,317.477,324.188,328.003,331.109,334.215,336.42,340.095,343.306,345.406,347.419,349.431,357.245,359.345,361.358,363.37,368.813,370.913,373.013,375.02599999999995,377.038,385.298,387.398,389.411,391.423,396.305,398.887,402.561,404.889,407.47,411.145,414.356,416.456,418.469,420.481,425.784,427.884,429.897,431.909,438.62,440.72,442.733,444.745,450.494,455.271,459.795,463.444,467.731,471.406,474.6,480.244,484.75,489.475,491.68,495.355,498.461,502.058,504.158,506.171,508.183,513.931,516.031" y="671.193" svg_rhmargin="518.044" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">16. Hassler, M. R., W. Pfeifer, T. H. Knocke-Abulesz, K. </text>
  <text x="317.477,323.619,327.294,329.621,332.728,335.834,338.039,341.714,344.925,347.025,349.03799999999995,351.05,357.193,359.293,361.306,363.318,368.961,371.166,373.87,378.394,381.605,383.836,387.651,389.979,392.079,394.092,396.104,401.853,403.953,405.96599999999995,407.978,414.356,416.684,420.359,424.008,428.295,435.505,439.32,444.098,448.875,450.975,452.988,455.0,458.675,461.379,463.392,465.404,469.219,471.424,473.524,475.537,477.549,481.749,485.949,490.149,494.349,496.449" y="682.9449999999999" svg_rhmargin="498.462" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">Geissler, G. Altorjai, K. Dieckmann, et al. 2013. </text>
  <text x="317.477,322.779,326.454,333.664,338.188,341.784,346.308,348.513,353.036,360.246,362.574,367.194,370.869,372.882,374.894,378.709,383.329,387.949,391.624,396.244,398.257,400.269,402.973,407.496,409.50899999999996,411.521,417.454,422.118,426.641,428.846,432.521,434.534,436.546,441.053,444.264,448.079,450.406,455.184,457.197,459.209,462.42,466.235,470.855,473.183,477.706,480.41,485.074,488.749,491.96,495.775,500.395,504.306,506.31899999999996,508.331,510.659,515.436" y="694.696" svg_rhmargin="517.449" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">Temozolomide added to whole brain radiotherapy in </text>
  <text x="317.477,322.096,325.911,328.615,330.943,334.618,339.395,342.099,345.205,347.21799999999996,349.23,355.163,357.49,360.194,364.858,366.871,368.883,376.093,380.818,383.023,385.726,388.054,392.674,394.879,398.554,400.56699999999995,402.579,407.085,410.296,414.111,416.439,421.216,423.229,425.241,432.451,436.126,438.83,442.645,445.751,448.455,452.27,455.376,459.051,462.158,464.171,466.183,470.706,473.288,475.301,477.313,482.09,486.614,491.391,494.585,494.585,497.692,504.902,508.717,510.922,513.127,516.32,516.32,519.969,523.644,525.849,528.054" y="706.447" svg_rhmargin="530.067" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:8.75px;font-style:NORMAL;font-weight:normal;">patients with multiple brain metastases of non- small- cell </text>
 </g>
</svg>
